Small cerebellar cortex volume in patients with active Cushing's syndrome

European Journal of Endocrinology

Volumn 171, Issue 4, 2014, Pages 461-469

  Santos, Alicia ^a,c   Resmini, Eugenia ^a   Crespo, Iris ^a   Pires, Patricia ^b   Vives Gilabert, Yolanda ^b   Granell, Esther ^a   Valassi, Elena ^a   Gómez Anson, Beatriz ^a   Martínez Momblán, M Antonia ^a,c   Mataró, Maria ^d   Webb, Susan M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BRAIN SIZE; CEREBELLUM CORTEX; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; FAS TEST; FEMALE; GRAY MATTER; HUMAN; HYDROCORTISONE URINE LEVEL; IMAGING SOFTWARE; INFORMATION PROCESSING; LANGUAGE TEST; LEFT HEMISPHERE; MALE; MENTAL PERFORMANCE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; REMISSION; RIGHT HEMISPHERE; SYSTOLIC BLOOD PRESSURE; TRAIL MAKING TEST B; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL MEMORY; WAIST CIRCUMFERENCE; WHITE MATTER; WISCONSIN CARD SORTING TEST; AGED; BLOOD; CASE CONTROL STUDY; MEMORY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATTERN RECOGNITION; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CEREBELLAR CORTEX; CROSS-SECTIONAL STUDIES; CUSHING SYNDROME; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; ORGAN SIZE; PATTERN RECOGNITION, VISUAL; QUALITY OF LIFE; TRIGLYCERIDES;

EID: 84907186764     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0371     Document Type: Article

References (50)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. (doi:10.1210/jc.2003-030871)
2. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
3. Starkman MN, Schteingart DE & Schork MA. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosomatic Medicine 1981 43 3-18. (doi:10.1097/ 00006842-198102000-00002)
4. Starkman MN, Giordani B, Berent S, Schork MA & Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine 2001 63 985-993. (doi:10.1097/00006842-200111000-00018)
5. León-Carrión J, Atutxa AM, Mangas MA, Soto-Moreno A, Pumar A, Leon-Justel A, Martín-Rodriguez JF, Venegas E, Domínguez-Morales MR & Leal-Cerro A. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clinical Endocrinology 2009 70 192-200. (doi:10.1111/j.1365-2265.2008.03355.x)
6. Dorn LD & Cerrone P. Cognitive function in patients with Cushing's syndrome: a longitudinal perspective. Clinical Nursing Research 2000 9 420-440. (doi:10.1177/10547730022158672)
7. Forget H, Lacroix A & Cohen H. Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 2002 27 367-383. (doi:10.1016/S0306-4530(01)00059-2)
8. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM & Romijn JA. Subtle cognitive impairments in patients with long-term cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2010 95 2699-2714. (doi:10.1210/ jc.2009-2032)
9. Resmini E, Santos A, Gómez-Anson B, Vives Y, Pires P, Crespo I, Portella MJ, de Juan-Delago M, Barahona MJ & Webb SM. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2012 97 663-671. (doi:10.1210/jc.2011-2231)
10. Joëls M, Karst H, Krugers HJ & Lucassen PJ. Chronic stress: implications for neural morphology, function and neurogenesis. Frontiers in Neuroendocrinology 2007 28 72-96. (doi:10.1016/j.yfrne. 2007.04.001)
11. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiological Reviews 2007 87 873-904. (doi:10.1152/physrev.00041.2006)
12. Michaud K, Forget H & Cohen H. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain and Cognition 2009 71 1-8. (doi:10.1016/j.bandc.2009.02.013)
13. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S & Schmidt R. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005 64 1704-1711. (doi:10.1212/01.WNL.0000161871.83614.BB)
14. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN & Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Archives of Neurology 2003 60 989-994. (doi:10.1001/archneur.60.7.989)
15. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, Dahle C, Gerstorf D & Acker JD. Regional brain changes in aging healthy adults: general trends, individual differences andmodifiers. Cerebral Cortex 2005 15 1676-1689. (doi:10.1093/cercor/bhi044)
16. Bourdeau I, Bard C, Noël B, Leclerc I, Cordeau MP, Bélair M, Lesage J, Lafontaine L & Lacroix A. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2002 87 1949-1954. (doi:10.1210/jcem.87.5.8493)
17. Simmons NE, Do HM, Lipper MH & Laws ER. Cerebral atrophy in Cushing's disease. Surgical Neurology 2000 53 72-76. (doi:10.1016/ S0090-3019(99)00197-4)
18. Gnjidić Z, Sajko T, Kudelić N, Malenica M, Vizner B, Vrkljan M, Hat J & Rumboldt Z. Reversible "brain atrophy" in patients with Cushing's disease. Collegium Antropologicum 2008 32 1165-1170.
19. Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA & Schteingart DE. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biological Psychiatry 1999 46 1595-1602. (doi:10.1016/S0006-3223(99)00203-6)
20. Momose KJ, Kjellberg RN & Kliman B. High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease. Radiology 1971 99 341-348. (doi:10.1148/99.2.341)
21. Tirapu-Ustarroz J, Luna-Lario P, Iglesias-Fernandez MD & Hernaez-Goni P. Cerebellar contribution to cognitive process: current advances. Revue Neurologique 2011 53 301-315.
22. Eckert MA, Keren NI, Roberts DR, Calhoun VS & Harris KC. Age-related changes in processing speed: unique contributions of cerebellar and prefrontal cortex. Frontiers in Human Neuroscience 2010 4 10. (doi:10.3389/neuro.09.010.2010)
23. Schmahmann JD & Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998 121 561-579. (doi:10.1093/brain/121.4.561)
24. Baldaçara L, Borgio JG, Lacerda AL & Jackowski AP. Cerebellum and psychiatric disorders. Revista Brasileira de Psiquiatria 2008 30 281-289. (doi:10.1590/S1516-44462008000300016)
25. Bekkelund SI, Pierre-Jerome C, Husby G & Mellgren SI. Quantitative cerebral MR in rheumatoid arthritis. AJNR. American Journal of Neuroradiology 1995 16 767-772.
26. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971 9 97-113. (doi:10.1016/0028-3932(71)90067-4)
27. Manor B, Newton E, Abduljalil A & Novak V. The relationship between brain volume and walking outcomes in older adults with and without diabetic peripheral neuropathy. Diabetes Care 2012 35 1907-1912. (doi:10.2337/dc11-2463)
28. Barahona MJ, Sucunza N, Resmini E, Fernández-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J & Webb SM. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2009 94 3365-3371. (doi:10.1210/jc.2009-0766)
29. Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SW et al. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. European Journal of Endocrinology 2008 158 623-630. (doi:10.1530/EJE-07-0762)
30. Ségonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK & Fischl B. A hybrid approach to the skull stripping problem in MRI. NeuroImage 2004 22 1060-1075. (doi:10.1016/j.neuroimage.2004.03.032)
31. Fichl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002 33 341-355. (doi:10.1016/S0896-6273(02)00569-X)
32. Fichl B, Salat DH, van der Kouwe AJ, Makris N, Ségonne F, Quinn BT & Dale AM. Sequence-independent segmentation of magnetic resonance images. NeuroImage 2004 23 (Suppl 1) S69-S84. (doi:10.1016/j.neuroimage.2004.07.016)
33. Andela CD, van der Werff SJ, Pannekoek JN, van den Berg SM, Meijer OC, van Buchem MA, Rombousts SA, van der Mast RC, Romijn JA, Tiemensma J et al. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study. European Journal of Endocrinology 2013 169 811-819. (doi:10.1530/EJE-13-0471)
34. Bhatt AJ, Feng Y, Wang J, Famuyide M & Hersey K. Dexamethasone induces apoptosis of progenitor cells in the subventricular zone and dentate gyrus of developing rat brain. Journal of Neuroscience Research 2013 91 1191-1202. (doi:10.1002/jnr.23232)
35. Wang J, Barak LS, Mook RA Jr & Chen W. Glucocorticoid hedgehog agonists in neurogenesis. Vitamins and Hormones 2011 87 207-215. (doi:10.1016/B978-0-12-386015-6.00030-5)
36. Tata DA, Marciano VA & Anderson BJ. Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. Journal of Comparative Neurology 2006 498 363-374. (doi:10.1002/cne.21071)
37. Kleen JK, Sitomer MT, Killeen PR & Conrad CD. Chronic stress impairs spatial memory and motivation for reward without disrupting motor ability and motivation to explore. Behavioral Neuroscience 2006 120 842-851. (doi:10.1037/0735-7044.120.4.842)
38. Galvan V & Jin K. Neurogenesis in the aging brain. Clinical Interventions in Aging 2007 2 605-610.
39. Balietti M, Fattoretti P, Giorgetti B, Casoli T, Di Stefano G, Platano D, Aicardi G, Lattanzio F & Bertoni-Freddari C. Effect of two medium chain triglycerides-supplemented diets on synaptic morphology in the cerebellar cortex of late-adult rats. Microscopy Research and Technique 2009 72 933-938. (doi:10.1002/jemt.20737)
40. Lauterbach EC, Harris JB & Bina WF III. Mood and neurobehavioral correlates of cerebellar lesions. Cognitive and Behavioral Neurology 2010 23 63-73. (doi:10.1097/WNN.0b013e3181cfb541)
41. Bauer PM, Hanson JL, Pierson RK, Davidson RJ & Pollak SD. Cerebellar volume and cognitive functioning in children who experienced early deprivation. Biological Psychiatry 2009 66 1100-1106. (doi:10.1016/ j.biopsych.2009.06.014)
42. Resmini E. Persistent comorbidities in Cushing's syndrome after endocrine cure. Advances in Endocrinology 2014. (doi:10.1155/2014/231432)
43. Heringa SM, van den Berg E, Reijmer YD, Nijpels G, Stehouwer CG, Teerlink T, Scheffer PG, van den Hurk K, Kappelle LJ, Dekker JM et al. Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population -the Hoorn Study. Psychoneuroendocrinology 2014 40 108-118. (doi:10.1016/j.psyneuen.2013.11.011)
44. Gustand J, Brickman AM, Paul RH, Browndyke J, Moser DJ, Ott BR, Gordon N, Haque O & Cohen RA. Progressive morphometric and cognitive changes in vascular dementia. Archives of Clinical Neuropsychology 2005 20 229-241. (doi:10.1016/j.acn.2004.07.001)
45. Scherder E. Functional circuits in cognitive aging and mild cognitive decline. In Aging and Dementia: Neuropsychology, Motor Skills, and Pain, ch 2, p 49. Amsterdam: VU University Press, 2011.
46. Dichgans J & Mauritz KH. Patterns and mechanisms of postural instability in patients with cerebellar lesions. Advances in Neurology 1983 39 633-643.
47. Horak FB & Diener HC. Cerebellar control of postural scaling and central set in stance. Journal of Neurophysiology 1994 72 479-493.
48. Singh D, Park W, Lewy MS & Jung ES. The effects of obesity and standing time on postural sway during prolonged quiet standing. Ergonomics 2009 52 977-986. (doi:10.1080/00140130902777636)
49. Fjeldstad C, Fjeldstad AS, Acree LS, Nickel KJ & Gardner AW. The influence of obesity on falls and quality of life. Dynamic Medicine 2008 7 4. (doi:10.1186/1476-5918-7-4)
50. Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age and Ageing 2006 35 (Suppl 2) ii37-ii41. (doi:10.1093/ageing/afl084)